UNIGE document Scientific Article
previous document  unige:77557  next document
add to browser collection

Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques

Fraga-Silva, Rodrigo A
Savergnini, Silvia Q
Nencioni, Alessio
Caffa, Irene
Soncini, Debora
Costa-Fraga, Fabiana P
De Sousa, Frederico B
show hidden authors show all authors [1 - 23]
Published in Thrombosis and haemostasis. 2014, vol. 111, no. 4, p. 736-747
Abstract Angiotensin (Ang)-(1-7), acting through the receptor Mas, has atheroprotective effects; however, its role on plaque vulnerability has been poorly studied. Here, we investigated the expression of the renin-angiotensin system (RAS) components in stable and unstable human carotid plaques. In addition, we evaluated the effects of the chronic treatment with an oral formulation of Ang-(1-7) in a mouse model of shear stress-determined carotid atherosclerotic plaque. Upstream and downstream regions of internal carotid plaques were obtained from a recently published cohort of patients asymptomatic or symptomatic for ischaemic stroke. Angiotensinogen and renin genes were strongly expressed in the entire cohort, indicating an intense intraplaque modulation of the RAS. Intraplaque expression of the Mas receptor mRNA was increased in the downstream portion of asymptomatic patients as compared to corresponding region in symptomatic patients. Conversely, AT1 receptor gene expression was not modified between asymptomatic and symptomatic patients. Treatment with Ang-(1-7) in ApoE-/- mice was associated with increased intraplaque collagen content in the aortic root and low shear stress-induced carotid plaques, and a decreased MMP-9 content and neutrophil and macrophage infiltration. These beneficial effects were not observed in the oscillatory shear stress-induced plaque. In vitro incubation with Ang-(1-7) did not affect ICAM-1 expression and apoptosis on cultured endothelial cells. In conclusion, Mas receptor is up regulated in the downstream portions of human stable carotid plaques as compared to unstable lesions. Treatment with the oral formulation of Ang-(1-7) enhances a more stable phenotype in atherosclerotic plaques, depending on the local pattern of shear stress forces.
Keywords Administration, OralAngiotensin I/administration & dosage/biosynthesis/geneticsAnimalsAnti-Inflammatory Agents/administration & dosageApolipoproteins E/geneticsCarotid Arteries/drug effects/metabolism/pathologyCase-Control StudiesDisease Models, AnimalHumansInflammation/drug therapy/immunologyMiceMice, Inbred C57BLMice, KnockoutPeptide Fragments/administration & dosage/biosynthesis/geneticsPlaque, Atherosclerotic/drug therapy/immunology
PMID: 24499778
Full text
Article (Published version) (5.9 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group L'athérosclérose et ses complications cliniques (591)
(ISO format)
FRAGA-SILVA, Rodrigo A et al. Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. In: Thrombosis and haemostasis, 2014, vol. 111, n° 4, p. 736-747. doi: 10.1160/TH13-06-0448 https://archive-ouverte.unige.ch/unige:77557

426 hits

0 download


Deposited on : 2015-11-23

Export document
Format :
Citation style :